US SB921

Requires the Secretary of Health and Human Services to complete a study within 3 years examining how frequently hospital emergency departments test for fentanyl and fentanyl-related substances during overdose cases, associated costs, benefits and risks, staff training needs, and implementation barriers

Mandates HHS issue guidance within 9 months after the study's completion on whether emergency departments should implement routine fentanyl testing for overdose patients

Study must assess patient privacy protections under HIPAA regulations and impacts on the patient-health care professional relationship

Guidance must address how hospitals can ensure clinicians know which substances are included in routine drug tests and identify available federal resources to assist with implementation

Applies to hospital emergency departments and independent freestanding emergency departments as defined under the Public Health Service Act